−0.3416EUR
−32.38 MEUR
152.23 KEUR
17.72 M
About AEGIRBIO AB
Sector
Industry
CEO
Marco Witteveen
Website
Headquarters
Lund
Founded
2019
ISIN
SE0014401121
FIGI
BBG00VVPS9S1
AegirBio AB engages in the development and commercialization of drug monitoring tests. Its products include Viraspec COVID-19 Saliva Test and moNATor. The company was founded on September 26, 2019 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange AEGIRBIO AB stocks are traded under the ticker 52Q.
Yes, you can track AEGIRBIO AB financials in yearly and quarterly reports right on TradingView.
52Q net income for the last quarter is −421.12 K EUR, while the quarter before that showed −1.55 M EUR of net income which accounts for 72.78% change. Track more AEGIRBIO AB financial stats to get the full picture.
No, 52Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 52Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AEGIRBIO AB stock right from TradingView charts — choose your broker and connect to your account.